aTYR PHARMA INC 4
4 · aTYR PHARMA INC · Filed Oct 5, 2015
Insider Transaction Report
Form 4
aTYR PHARMA INCLIFE
Blackburn Kelly
See Remarks
Transactions
- Award
Employee Stock Option (right to buy)
2015-10-01+11,581→ 11,581 totalExercise: $10.24→ Common Stock (11,581 underlying) - Award
Employee Stock Option (right to buy)
2015-10-01+45,500→ 45,500 totalExercise: $10.24Exp: 2025-10-01→ Common Stock (45,500 underlying)
Footnotes (2)
- [F1]The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on November 1, 2015, such that this option will be fully exercisable on October 1, 2019. This option is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.
- [F2]The shares subject to this option shall vest and become exercisable, if at all, in 48 equal monthly installments upon the achievement of certain performance goals, which must be achieved by October 1, 2017, or such option will be subject to immediate forfeiture. This option is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.